118460-23-4Relevant articles and documents
Is there a scaffolding domain within the structure of the immunosuppressive agent cyclosporin A (CsA)? Studies of the cyclophilin binding domain of CsA
Schreiber,Anthony,Dorsey,Hawley
, p. 6577 - 6580 (1988)
-
THERAPEUTIC COMPOUNDS AS INHIBITORS OF THE OREXIN-1 RECEPTOR
-
Page/Page column 95, (2016/03/19)
The present invention relates to compounds that are inhibitors of the orexin-1 receptor. The compounds have the structural formula I defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with orexin-1 receptor activity.
L-alanine-derived chiral ligands for asymmetric addition of diethylzinc to aldehydes
Kang, Seock Yong,Baek, Jinho,Kang, Kyoung Hee,Lee, Jeong-Ae,Park, Yong Sun
, p. 3125 - 3128 (2012/10/30)
-